Literature DB >> 27654981

Are carriers of CYP21A2 mutations less vulnerable to psychological stress? A population-based national cohort study.

Anna Nordenström1,2, Agnieszka Butwicka3,4, Angelica Lindén Hirschberg1,5, Catarina Almqvist3,6, Agneta Nordenskjöld1,7,8, Henrik Falhammar9,10, Louise Frisén11,12.   

Abstract

BACKGROUND: Congenital adrenal hyperplasia (CAH) is one of the most common monogenic autosomal recessive disorders with an incidence of one in 15 000. About one in 70 individuals in the general population are carriers of a severe CYP21A2 mutation. It has been suggested that this confers a survival advantage, perhaps as a result of increased activity in the hypothalamic-pituitary-adrenal axis. We investigated vulnerability to psychological stress in obligate carriers.
METHOD: The Swedish CAH Registry encompasses more than 600 patients. Parents, that is obligate carriers of the CYP21A2 mutation, were identified through the Multigeneration Register. The diagnosis of the child was used as the psychological stressor. Psychiatric diagnoses before and after the birth of a child with CAH were compared to those of controls derived from (i) the general population, (ii) parents of children with hypospadias and (iii) parents of children with diabetes mellitus type 1 (T1DM).
RESULTS: Parents of children with CAH had less risk of being diagnosed with any psychiatric disorder (OR, 0·6), an affective disorder (OR, 0·5) or substance misuse (OR, 0·5) after the diagnosis of the child, compared to the general population. Their risk was also decreased compared to parents of a child with hypospadias (OR, 0·6, 0·4 and 0·2, respectively) and parents of a child with T1DM (OR 0·7, 0·6 and 0·2, respectively). The CYP21A2 carriers had a lower risk of developing mood and stress-related disorders after the diagnosis of the child.
CONCLUSION: Obligate CYP21A2 carriers had a reduced risk of a psychiatric diagnosis and were less vulnerable to a psychologically stressful situation, at least with respect to receiving a psychiatric diagnosis. This indicates a better ability to cope with psychological stress among heterozygous carriers of severe CYP21A2 mutations, which may contribute to the apparent survival advantage.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27654981     DOI: 10.1111/cen.13242

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  4 in total

1.  Complement component 4 variations may influence psychopathology risk in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Qizong Lao; Marcia Des Jardin; Rahul Jayakrishnan; Monique Ernst; Deborah P Merke
Journal:  Hum Genet       Date:  2018-11-21       Impact factor: 4.132

2.  Corticosteroid-Binding Globulin is expressed in the adrenal gland and its absence impairs corticosterone synthesis and secretion in a sex-dependent manner.

Authors:  José Gulfo; Ricard Castel; Angelo Ledda; María Del Mar Romero; Montserrat Esteve; Mar Grasa
Journal:  Sci Rep       Date:  2019-09-30       Impact factor: 4.379

Review 3.  Characteristics of In2G Variant in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.

Authors:  Mirjana Kocova; Paola Concolino; Henrik Falhammar
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-24       Impact factor: 5.555

Review 4.  Long-Term Outcomes of Congenital Adrenal Hyperplasia.

Authors:  Anna Nordenström; Svetlana Lajic; Henrik Falhammar
Journal:  Endocrinol Metab (Seoul)       Date:  2022-07-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.